Restricted Cash

3 Months Ended

Mar. 31, 2020

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]

Cash And Cash Equivalents Disclosure [Text Block]

Note 13 – Restricted Cash

The Company has restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements have been deposited into interest bearing accounts that earned less than $0.1 million in each of the three months ended March 31, 2020 and 2019, respectively, offset by $0.2 million of net payments during each of the three months ended March 31, 2020 and 2019, respectively. Due to the restricted nature of the proceeds, a corresponding deferred credit was established in other non-current liabilities for an equal and offsetting amount, and will remain until the restrictions lapse or the funds are exhausted via payments of claims and costs of defense.

The following table provides a reconciliation of cash, cash equivalents and restricted cash as of March 31, 2020 and 2019 and December 31, 2019 and 2018:

	March 31,				December 31,
	2020		2019		2019		2018
Cash and cash equivalents	$	316,437	$	71,960	$	123,524	$	104,147
Restricted cash included in other current assets		34		—		353		—
Restricted cash included in other assets		19,480		20,153		19,678		20,278
Cash, cash equivalents and restricted cash	$	335,951	$	92,113	$	143,555	$	124,425